Cite
Assessment of the Safety of Tofacitinib Among Patients With Psoriasis: A Systematic Review and Meta-Analysis.
MLA
Alqahtani, Saad, et al. “Assessment of the Safety of Tofacitinib Among Patients With Psoriasis: A Systematic Review and Meta-Analysis.” Cureus, vol. 16, no. 9, Sept. 2024, p. e70196. EBSCOhost, https://doi.org/10.7759/cureus.70196.
APA
Alqahtani, S., Khalil, S., Bakhamees, B. H., Almutairi, L. M., Alyahya, M. A., Alghuyaythat, W. K. Z., Alabdulqader, F. K., Aldossary, D., Asiri, S. T. B., Alsulami, T. A., Hussain, A. A., & Alaamer, M. A. (2024). Assessment of the Safety of Tofacitinib Among Patients With Psoriasis: A Systematic Review and Meta-Analysis. Cureus, 16(9), e70196. https://doi.org/10.7759/cureus.70196
Chicago
Alqahtani, Saad, Samia Khalil, Basel H Bakhamees, Layan M Almutairi, Mariyah A Alyahya, Waleed Khalid Z Alghuyaythat, Fatimah K Alabdulqader, et al. 2024. “Assessment of the Safety of Tofacitinib Among Patients With Psoriasis: A Systematic Review and Meta-Analysis.” Cureus 16 (9): e70196. doi:10.7759/cureus.70196.